-
Integrated genomic analysis identifies driver genes and cisplatin-resistant progenitor phenotype in pediatric liver cancer
Study
EGAS00001005108
-
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple negative breast cancer: phase 2 adaptive BELLINI trial. WES
Study
EGAS50000000568
-
A_study_of_the_genetic_basis_of_evation_by_Acute_Myeloid_Leukaemia_of_Graft_vs_Leukaemia_effects_after_allogeneic_bone_marrow_transplantation
Study
EGAS00001000145
-
Identification of Modifiers of 22q11.2 Deletion Syndrome in Whole Genome Sequence - CIDR
Study
phs002514
-
Privacy Notice for EGA Web user
Documentation
data-protection/privacy-notice/ega-website
-
CSER: South-Seq: DNA Sequencing for Newborn Nurseries in the South
Study
phs002307
-
33 patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) had whole exome sequencing performed. Cells were sorted by FACSAria using CD138, CD19 and CD56 to obtain a pure abnormal plasma cell population. Generated somatic variants were compared to a previous study of 463 multiple myeloma patients.
Study
EGAS00001001658
-
DAC Portal documentation
Documentation
access/data-access-committee/dac-portal
-
Defective Homologous Recombination DNA Repair as Therapeutic Target in Advanced-Stage Chordoma (HIPO_021)
Study
EGAS00001002720
-
Clinical outcomes in ctDNA-positive urothelial carcinoma patients treated with adjuvant immunotherapy
Study
EGAS00001004997